Compare ARCT & XRPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ARCT | XRPN |
|---|---|---|
| Founded | 2013 | 2024 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Blank Checks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 293.9M | 344.1M |
| IPO Year | 2019 | 2025 |
| Metric | ARCT | XRPN |
|---|---|---|
| Price | $10.74 | $15.47 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 13 | 0 |
| Target Price | ★ $23.80 | N/A |
| AVG Volume (30 Days) | 653.3K | ★ 1.3M |
| Earning Date | 11-09-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 20.00 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $82,031,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $64.21 | N/A |
| P/E Ratio | ★ N/A | $72.74 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $5.50 | $10.10 |
| 52 Week High | $17.96 | $48.00 |
| Indicator | ARCT | XRPN |
|---|---|---|
| Relative Strength Index (RSI) | 38.81 | 49.47 |
| Support Level | $6.53 | $10.89 |
| Resistance Level | $17.85 | $48.00 |
| Average True Range (ATR) | 1.13 | 4.14 |
| MACD | -0.26 | -0.74 |
| Stochastic Oscillator | 8.84 | 4.06 |
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases. It operates in one business segment, which includes all activities related to the discovery, development, and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC and LUNAR-CF. Its Vaccine candidates include LUNAR-FLU, KOSTAIVE XBB.1.5, KOSTAIVE, and Others.
Evernorth Holdings Incis a purpose-built investment vehicle focused on holding XRP through the public equity markets. It provides institutional investors with exposure to XRP through a publicly traded vehicle. The company manages its XRP assets through activities that may include the acquisition of XRP, portfolio management, yield generation strategies, and geographic expansion. The company also focuses on the XRP Ledger, a public blockchain designed to facilitate financial transactions.